485 related articles for article (PubMed ID: 28818973)
1. Mutations in the promoter of the telomerase gene
Chiba K; Lorbeer FK; Shain AH; McSwiggen DT; Schruf E; Oh A; Ryu J; Darzacq X; Bastian BC; Hockemeyer D
Science; 2017 Sep; 357(6358):1416-1420. PubMed ID: 28818973
[No Abstract] [Full Text] [Related]
2. TERT promoter mutations and telomeres during tumorigenesis.
Lorbeer FK; Hockemeyer D
Curr Opin Genet Dev; 2020 Feb; 60():56-62. PubMed ID: 32163830
[TBL] [Abstract][Full Text] [Related]
3. TPP1 promoter mutations cooperate with TERT promoter mutations to lengthen telomeres in melanoma.
Chun-On P; Hinchie AM; Beale HC; Gil Silva AA; Rush E; Sander C; Connelly CJ; Seynnaeve BKN; Kirkwood JM; Vaske OM; Greider CW; Alder JK
Science; 2022 Nov; 378(6620):664-668. PubMed ID: 36356143
[TBL] [Abstract][Full Text] [Related]
4. TERT promoter C228T mutation in neural progenitors confers growth advantage following telomere shortening in vivo.
Miki S; Koga T; Mckinney AM; Parisian AD; Tadokoro T; Vadla R; Marsala M; Hevner RF; Costello JF; Furnari F
Neuro Oncol; 2022 Dec; 24(12):2063-2075. PubMed ID: 35325218
[TBL] [Abstract][Full Text] [Related]
5. Telomere length, telomerase reverse transcriptase promoter mutations, and melanoma risk.
Rachakonda S; Kong H; Srinivas N; Garcia-Casado Z; Requena C; Fallah M; Heidenreich B; Planelles D; Traves V; Schadendorf D; Nagore E; Kumar R
Genes Chromosomes Cancer; 2018 Nov; 57(11):564-572. PubMed ID: 30203894
[TBL] [Abstract][Full Text] [Related]
6. Occurrence, functionality and abundance of the TERT promoter mutations.
Rachakonda S; Hoheisel JD; Kumar R
Int J Cancer; 2021 Dec; 149(11):1852-1862. PubMed ID: 34313327
[TBL] [Abstract][Full Text] [Related]
7. Classifying Melanoma by TERT Promoter Mutational Status.
Shaughnessy M; Njauw CN; Artomov M; Tsao H
J Invest Dermatol; 2020 Feb; 140(2):390-394.e1. PubMed ID: 31425705
[TBL] [Abstract][Full Text] [Related]
8. Cancer-associated TERT promoter mutations abrogate telomerase silencing.
Chiba K; Johnson JZ; Vogan JM; Wagner T; Boyle JM; Hockemeyer D
Elife; 2015 Jul; 4():. PubMed ID: 26194807
[TBL] [Abstract][Full Text] [Related]
9. TERT promoter mutations in telomere biology.
Heidenreich B; Kumar R
Mutat Res Rev Mutat Res; 2017; 771():15-31. PubMed ID: 28342451
[TBL] [Abstract][Full Text] [Related]
10. UV light-induced dual promoter mutations dismantle the telomeric guardrails in melanoma.
Sanford SL; Opresko PL
DNA Repair (Amst); 2023 Feb; 122():103446. PubMed ID: 36603239
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms underlying the activation of TERT transcription and telomerase activity in human cancer: old actors and new players.
Yuan X; Larsson C; Xu D
Oncogene; 2019 Aug; 38(34):6172-6183. PubMed ID: 31285550
[TBL] [Abstract][Full Text] [Related]
12. Telomeres and Telomerase in Cutaneous Squamous Cell Carcinoma.
Ventura A; Pellegrini C; Cardelli L; Rocco T; Ciciarelli V; Peris K; Fargnoli MC
Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30884806
[TBL] [Abstract][Full Text] [Related]
13. DNA hypermethylation within TERT promoter upregulates TERT expression in cancer.
Lee DD; Leão R; Komosa M; Gallo M; Zhang CH; Lipman T; Remke M; Heidari A; Nunes NM; Apolónio JD; Price AJ; De Mello RA; Dias JS; Huntsman D; Hermanns T; Wild PJ; Vanner R; Zadeh G; Karamchandani J; Das S; Taylor MD; Hawkins CE; Wasserman JD; Figueiredo A; Hamilton RJ; Minden MD; Wani K; Diplas B; Yan H; Aldape K; Akbari MR; Danesh A; Pugh TJ; Dirks PB; Castelo-Branco P; Tabori U
J Clin Invest; 2019 Jan; 129(1):223-229. PubMed ID: 30358567
[TBL] [Abstract][Full Text] [Related]
14. The role of telomere shortening in carcinogenesis: A hybrid stochastic-deterministic approach.
Rodriguez-Brenes IA; Komarova NL; Wodarz D
J Theor Biol; 2019 Jan; 460():144-152. PubMed ID: 30315815
[TBL] [Abstract][Full Text] [Related]
15. TERT promoter mutations are frequent in cutaneous basal cell carcinoma and squamous cell carcinoma.
Griewank KG; Murali R; Schilling B; Schimming T; Möller I; Moll I; Schwamborn M; Sucker A; Zimmer L; Schadendorf D; Hillen U
PLoS One; 2013; 8(11):e80354. PubMed ID: 24260374
[TBL] [Abstract][Full Text] [Related]
16. Telomere shortening produces an inflammatory environment that increases tumor incidence in zebrafish.
Lex K; Maia Gil M; Lopes-Bastos B; Figueira M; Marzullo M; Giannetti K; Carvalho T; Ferreira MG
Proc Natl Acad Sci U S A; 2020 Jun; 117(26):15066-15074. PubMed ID: 32554492
[TBL] [Abstract][Full Text] [Related]
17. Telomeres: Implications for Cancer Development.
Bernal A; Tusell L
Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29351238
[TBL] [Abstract][Full Text] [Related]
18. Revisiting Telomere Shortening in Cancer.
Okamoto K; Seimiya H
Cells; 2019 Jan; 8(2):. PubMed ID: 30709063
[TBL] [Abstract][Full Text] [Related]
19. Impairment of the telomere/telomerase system and genomic instability are associated with keratinocyte immortalization induced by the skin human papillomavirus type 38.
Gabet AS; Accardi R; Bellopede A; Popp S; Boukamp P; Sylla BS; Londoño-Vallejo JA; Tommasino M
FASEB J; 2008 Feb; 22(2):622-32. PubMed ID: 17898088
[TBL] [Abstract][Full Text] [Related]
20. Distinct senescence mechanisms restrain progression of dysplastic nevi.
Lorbeer FK; Rieser G; Goel A; Wang M; Oh A; Yeh I; Bastian BC; Hockemeyer D
PNAS Nexus; 2024 Feb; 3(2):pgae041. PubMed ID: 38371417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
